Information:
Fel:
ID
34232
Beskrivning
POLish Bifurcation Optimal Stenting Study; ODM derived from: https://clinicaltrials.gov/show/NCT02192840
Länk
https://clinicaltrials.gov/show/NCT02192840
Nyckelord
Versioner (1)
- 2019-01-15 2019-01-15 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
15 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Coronary Artery Disease NCT02192840
Eligibility Coronary Artery Disease NCT02192840
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Artery Disease NCT02192840
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
subject able to verbally confirm understandings of risks, benefits of receiving pci for true bifurcation lesions, and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
boolean
ID.2
Item
target main branch lesion(s) located in a native coronary artery with diameter of ≥
boolean
ID.3
Item
2.5 mm and ≤ 4.5 mm. target side branch lesion(s) located in a native coronary artery with diameter of ≥ 2.0 mm.
boolean
ID.4
Item
target lesion(s) amenable for pci with balloon angioplasty of the side branch.
boolean
ID.5
Item
stemi
boolean
ID.6
Item
non-cardiac co-morbid conditions are present with life expectancy <1 year or that may result in protocol non-compliance (per site investigator's medical judgment).
boolean
ID.7
Item
subjects who refuse to give informed consent.
boolean
ID.8
Item
subjects with lvef<30%
boolean
ID.9
Item
subjects with moderate or severe degree valvular heart disease or primary cardiomyopathy
boolean